WARSAW, Poland, March 15, 2012 /PRNewswire/ --
Elsevier, a world-leading provider of scientific, technical and
medical information products and services, and the Czech Society of
Cardiology and Czech Society for Cardiovascular Surgery, announce
the re-launch of journal Cor et Vasa.
Cor et Vasa is the official journal of the Czech Society
of Cardiology, which was the first to publish breakthrough
guidelines for the treatment of acute myocardial infarction
recommending primary angioplasty as first choice therapy. It is
open to all novel research in the field of cardiology and is
recognized as a distinct international research forum gaining
significant interest and contributions from all Central and Easter
European countries.
Elsevier publishes Cor et Vasa in two versions; an
English version accessible online only through SciVerse
ScienceDirect, and a print version based on translations of the
English articles to Czech. The Czech Society of Cardiology believes
that this change will help re-introduce Cor et Vasa to the
international medical community and to offer the journal as a
publishing platform for researchers from other countries.
"With Cor et Vasa now published in two languages, we aim
to reach out to a greater range of authors and readers based
worldwide, not just in Eastern and Central Europe, and consequently to build a
higher journal prestige for our local authors and the societies,"
Prof. Michael Aschermann,
Editor-in-Chief of Cor et Vasa comments. "We hope that with
the help and experience of Elsevier, Cor et Vasa will find
its place amongst top journals within the field of cardiology."
"We are delighted to be launching such a prominent journal which
throughout the years served as a unique forum for the exchange of
knowledge," Ewa Kittel Prejs,
Publishing Director Elsevier Poland said. "It is a pleasure to
cooperate with highly renowned members of the society who make
important international contributions to the development of
medicine through publication of invaluable and milestones
researches."
Cor et Vasa publishes research articles focusing on all
core topics in cardiology, with a preference for clinical
cardiology. Twice a year an issue will be dedicated to one key
topic for which a high profile Guest Editor will be invited to
ensure highest possible quality of the journal content.
For more information about the journal go to:
http://www.elsevier.com/locate/crvasa.
About Cor et Vasa
Cor et Vasa publishes 6 times a year and covers all
aspects of cardiology, angiology, cardiovascular surgery,
cardiovascular imaging, pediatric cardiology, hypertension,
cardiovascular prevention and some aspects of interventional
radiology. It features editorials, review articles and original
research as well as preliminary, fast-track and special
communications (clinical and experimental).
The journal publishes in two versions with the same content: one
being the on-line version of Cor et Vasa which is published
in English only; the other printed version is largely in Czech (the
manuscripts from the English version are translated into Czech by
local experts).
About Elsevier
Elsevier is a world-leading provider of scientific, technical and
medical information products and services. The company works in
partnership with the global science and health communities to
publish more than 2,000 journals, including The Lancet and
Cell, and close to 20,000 book titles, including major
reference works from Mosby and Saunders. Elsevier's online
solutions include SciVerse ScienceDirect, SciVerse Scopus, Reaxys,
MD Consult and Mosby's Nursing Suite, which enhance the
productivity of science and health professionals, and the SciVal
suite and MEDai's Pinpoint Review, which help research and health
care institutions deliver better outcomes more
cost-effectively.
A global business headquartered in Amsterdam, Elsevier employs 7,000 people
worldwide. The company is part of Reed Elsevier Group PLC, a
world-leading publisher and information provider, which is jointly
owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols
are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and
ENL (New York Stock Exchange).
Media contact
Ewa Kittel-Prejs
Elsevier
+48-509-997-930
e.kittel-prejs@elsevier.com